BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Elliott Sigal Named Acting President Of Bristol-Myers Squibb Pharmaceutical Research Institute


10/19/2005 5:11:54 PM

PRINCETON, N.J., Oct. 22 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company announced today that Elliott Sigal, M.D., Ph.D., senior vice president, Global Clinical and Pharmaceutical Development, will serve as acting president of the company's Pharmaceutical Research Institute (PRI). James B.D. Palmer, M.D., F.R.C.P., chief scientific officer and president of the PRI, recently underwent surgery.

Dr. Sigal has been a member of the company's Executive Committee since May 2001, and for the last several years has led the Global Clinical and Pharmaceutical Development arm of the PRI, working closely with Dr. Palmer. Dr. Sigal will direct the efforts of the global research and development organization, with a focus on development of new medicines and advancing the pipeline. Dr. Sigal began his career with the company in 1997 as a vice president within Drug Discovery. An expert in genomics, Dr. Sigal built the company's capability and expertise in the application of pharmacogenomics to drug discovery and development.

Bristol-Myers Squibb Company is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.

Bristol-Myers Squibb Company

CONTACT: Media - Robert Hutchison, +1-609-252-3901; or Investors - JohnElicker, +1-212-546-3775, both of Bristol-Myers Squibb Company



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES